GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells

BACKGROUND: Aromatase inhibitors (AI) that inhibit breast cancer cell growth by blocking estrogen synthesis have become the treatment of choice for post-menopausal women with estrogen receptor positive (ER(+)) breast cancer. However, some patients display de novo or acquired resistance to AI. Intera...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Abrhale, Tesfom, Brodie, Angela, Sabnis, Gauri, Macedo, Luciana, Tian, Changsheng, Yue, Binbin, Serrero, Ginette
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2011
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3129588/
https://ncbi.nlm.nih.gov/pubmed/21658239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-231
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars